Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Georges

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Blood|May 23, 2001
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effectsP A McSweeney, D Niederwieser, J A Shizuru, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2013
Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantationRainer Storb, Boglarka Gyurkocza, Barry E Storer, et al.
Haematologica|June 6, 2020
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decadesJason P Cooper, Barry E Storer, Noa Granot, et al.
The New England Journal of Medicine|January 4, 2018
Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaKeith M Sullivan, Ellen A Goldmuntz, Lynette Keyes-Elstein, et al.
Plos One|February 8, 2011
Expanding the diversity of mycobacteriophages: insights into genome architecture and evolutionWelkin H Pope, Deborah Jacobs-Sera, Daniel A Russell, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Blood|May 23, 2001
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effectsP A McSweeney, D Niederwieser, J A Shizuru, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2013
Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantationRainer Storb, Boglarka Gyurkocza, Barry E Storer, et al.
Haematologica|June 6, 2020
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decadesJason P Cooper, Barry E Storer, Noa Granot, et al.
The New England Journal of Medicine|January 4, 2018
Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaKeith M Sullivan, Ellen A Goldmuntz, Lynette Keyes-Elstein, et al.
Plos One|February 8, 2011
Expanding the diversity of mycobacteriophages: insights into genome architecture and evolutionWelkin H Pope, Deborah Jacobs-Sera, Daniel A Russell, et al.
Pageof 14